181 related articles for article (PubMed ID: 36359014)
1. Atypical Substrates of the Organic Cation Transporter 1.
Redeker KM; Jensen O; Gebauer L; Meyer-Tönnies MJ; Brockmöller J
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36359014
[TBL] [Abstract][Full Text] [Related]
2. Multispecific Organic Cation Transporter 1 (OCT1) from Bos taurus Has High Affinity and Slow Binding Kinetics towards Prostaglandin E2.
He X; Garza D; Nigam SK; Chang G
PLoS One; 2016; 11(4):e0152969. PubMed ID: 27046168
[TBL] [Abstract][Full Text] [Related]
3. Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).
Nies AT; Herrmann E; Brom M; Keppler D
Naunyn Schmiedebergs Arch Pharmacol; 2008 Feb; 376(6):449-61. PubMed ID: 18157518
[TBL] [Abstract][Full Text] [Related]
4. Role of the plasma membrane transporter of organic cations OCT1 and its genetic variants in modern liver pharmacology.
Lozano E; Herraez E; Briz O; Robledo VS; Hernandez-Iglesias J; Gonzalez-Hernandez A; Marin JJ
Biomed Res Int; 2013; 2013():692071. PubMed ID: 23984399
[TBL] [Abstract][Full Text] [Related]
5. Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration.
Tzvetkov MV; dos Santos Pereira JN; Meineke I; Saadatmand AR; Stingl JC; Brockmöller J
Biochem Pharmacol; 2013 Sep; 86(5):666-78. PubMed ID: 23835420
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
Choi MK; Song IS
Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of promiscuous substrate transport by Organic Cation Transporter 1.
Zeng YC; Sobti M; Quinn A; Smith NJ; Brown SHJ; Vandenberg JI; Ryan RM; O'Mara ML; Stewart AG
Nat Commun; 2023 Oct; 14(1):6374. PubMed ID: 37821493
[TBL] [Abstract][Full Text] [Related]
8. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations.
Jonker JW; Wagenaar E; Van Eijl S; Schinkel AH
Mol Cell Biol; 2003 Nov; 23(21):7902-8. PubMed ID: 14560032
[TBL] [Abstract][Full Text] [Related]
9. In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1.
Li L; Song F; Tu M; Wang K; Zhao L; Wu X; Zhou H; Xia Z; Jiang H
Int J Pharm; 2014 Apr; 465(1-2):5-10. PubMed ID: 24530383
[TBL] [Abstract][Full Text] [Related]
10. Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1.
Meyer MJ; Schreier PCF; Basaran M; Vlasova S; Seitz T; Brockmöller J; Zdrazil B; Tzvetkov MV
J Biol Chem; 2022 Jun; 298(6):101974. PubMed ID: 35469921
[TBL] [Abstract][Full Text] [Related]
11. Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib.
Herraez E; Lozano E; Macias RI; Vaquero J; Bujanda L; Banales JM; Marin JJ; Briz O
Hepatology; 2013 Sep; 58(3):1065-73. PubMed ID: 23532667
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1.
Shu Y; Leabman MK; Feng B; Mangravite LM; Huang CC; Stryke D; Kawamoto M; Johns SJ; DeYoung J; Carlson E; Ferrin TE; Herskowitz I; Giacomini KM;
Proc Natl Acad Sci U S A; 2003 May; 100(10):5902-7. PubMed ID: 12719534
[TBL] [Abstract][Full Text] [Related]
13. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene.
Jonker JW; Wagenaar E; Mol CA; Buitelaar M; Koepsell H; Smit JW; Schinkel AH
Mol Cell Biol; 2001 Aug; 21(16):5471-7. PubMed ID: 11463829
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of Organic Cation Transporter 1 (OCT1) Substrates in Oct1/2 Knockout Mice and Species Difference in Hepatic OCT1-Mediated Uptake.
Morse BL; Kolur A; Hudson LR; Hogan AT; Chen LH; Brackman RM; Sawada GA; Fallon JK; Smith PC; Hillgren KM
Drug Metab Dispos; 2020 Feb; 48(2):93-105. PubMed ID: 31771949
[TBL] [Abstract][Full Text] [Related]
15. Combined and independent effects of OCT1 and CYP2D6 on the cellular disposition of drugs.
Gebauer L; Dücker C; Jensen O; Brockmöller J
Biomed Pharmacother; 2023 May; 161():114454. PubMed ID: 36871537
[TBL] [Abstract][Full Text] [Related]
16. Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1.
Jensen O; Gebauer L; Brockmöller J; Dücker C
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216120
[TBL] [Abstract][Full Text] [Related]
17. Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine.
Meyer MJ; Seitz T; Brockmöller J; Tzvetkov MV
PLoS One; 2017; 12(12):e0189521. PubMed ID: 29236753
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1).
Chen EC; Khuri N; Liang X; Stecula A; Chien HC; Yee SW; Huang Y; Sali A; Giacomini KM
J Med Chem; 2017 Apr; 60(7):2685-2696. PubMed ID: 28230985
[TBL] [Abstract][Full Text] [Related]
19. Effect of pregnane X receptor ligand on pharmacokinetics of substrates of organic cation transporter Oct1 in rats.
Maeda T; Oyabu M; Yotsumoto T; Higashi R; Nagata K; Yamazoe Y; Tamai I
Drug Metab Dispos; 2007 Sep; 35(9):1580-6. PubMed ID: 17553914
[TBL] [Abstract][Full Text] [Related]
20. Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
Meyer MJ; Neumann VE; Friesacher HR; Zdrazil B; Brockmöller J; Tzvetkov MV
J Med Chem; 2019 Nov; 62(21):9890-9905. PubMed ID: 31597043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
